Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Friday. The brokerage set a “hold” rating on the stock.

Separately, Benchmark reiterated a “speculative buy” rating and set a $1.25 price objective on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Price Performance

Shares of NYSE MLSS opened at $0.80 on Friday. The stock has a market capitalization of $62.09 million, a P/E ratio of -11.39 and a beta of 1.10. The business has a fifty day moving average price of $0.81 and a 200 day moving average price of $0.86. Milestone Scientific has a 1-year low of $0.52 and a 1-year high of $1.10.

Insider Activity at Milestone Scientific

In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the sale, the director now directly owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. This represents a 2.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 24.75% of the stock is owned by insiders.

Institutional Trading of Milestone Scientific

A number of hedge funds have recently modified their holdings of MLSS. Y Intercept Hong Kong Ltd purchased a new stake in Milestone Scientific during the third quarter worth $48,000. World Investment Advisors LLC purchased a new position in Milestone Scientific in the third quarter valued at $91,000. Finally, Geode Capital Management LLC raised its position in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after acquiring an additional 31,572 shares during the period. Hedge funds and other institutional investors own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.